Todd Druley, MD, PhD

Todd Druley, MD, PhD established his career as a board-certified pediatric oncologist and tenured physician-scientist in molecular genomics at Washington University School of Medicine and St. Louis Children’s Hospital. Todd’s research program focused on improving molecular diagnostics for a variety of cancers, but specifically myeloid leukemia. He has published over 60 peer reviewed manuscripts, patented error-corrected NGS methods to improve AML MRD detection by next-generation sequencing and built clinical programs based on genetic predisposition to cancer. Prior to joining Mission Bio, he served as CMO of ArcherDX and ANGLE Biosciences since 2019.